Literature DB >> 25175688

Tapasin and human leukocyte antigen class I dysregulation correlates with survival in glioblastoma multiforme.

Camilla Thuring, Linda Geironson, Kajsa Paulsson1.   

Abstract

Human leukocyte antigen class I (HLA-I) molecules present antigenic peptides to cytotoxic CD8(+) T cells. Downregulation of peptide:HLA-I complexes is common in tumors and results in tumor immune escape variants. Also molecules involved in the maturation of HLA-I have been demonstrated to be dysregulated in malignant neoplasms. We here set out to investigate the antigen presentation capabilities of a set of 12 glioblastoma multiforme (GBM) tumors based on the expression of HLA-I. Moreover, we analyzed the expression of tapasin, a protein dedicated and essential to HLA-I maturation, as well as the infiltration of CD8+ cells using immunohistochemistry on paraffin-embedded sections. Comparison of different GBMs showed a variation in expression of both HLA-I heavy chain (HC) and tapasin. Interestingly, the expression of tapasin and HLA-I HC correlated significantly (p=0.0002) suggesting tapasin to be a key factor for efficient HLA-I antigen presentation in GBMs. Although no statistically significant correlation between CD8(+) cells and survival was found, probably due to a very low number of infiltrating CD8(+) cells at the time of surgical resection, both tapasin and HLA-I HC levels significantly correlated with survival. We suggest that analysis of expression of tapasin and/or HLA-I may be of value as prognostic tool for GBM patients, especially when considering immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25175688     DOI: 10.2174/1871520614666140825110402

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  4 in total

1.  Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.

Authors:  Yosuke Shionoya; Takayuki Kanaseki; Sho Miyamoto; Serina Tokita; Ayumi Hongo; Yasuhiro Kikuchi; Vitaly Kochin; Kazue Watanabe; Ryota Horibe; Hiroshi Saijo; Tomohide Tsukahara; Yoshihiko Hirohashi; Hiroki Takahashi; Noriyuki Sato; Toshihiko Torigoe
Journal:  Oncoimmunology       Date:  2017-01-03       Impact factor: 8.110

2.  HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.

Authors:  Camilla Thuring; Elna Follin; Linda Geironson; Eva Freyhult; Victoria Junghans; Mikkel Harndahl; Søren Buus; Kajsa M Paulsson
Journal:  Br J Cancer       Date:  2015-08-27       Impact factor: 7.640

3.  Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer.

Authors:  Lena Sokol; Viktor H Koelzer; Tilman T Rau; Eva Karamitopoulou; Inti Zlobec; Alessandro Lugli
Journal:  J Transl Med       Date:  2015-08-27       Impact factor: 5.531

4.  Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner.

Authors:  Victoria Walker-Sperling; Jean C Digitale; Mathias Viard; Maureen P Martin; Arman Bashirova; Yuko Yuki; Veron Ramsuran; Smita Kulkarni; Vivek Naranbhai; Hongchuan Li; Stephen K Anderson; Lauren Yum; Robert Clifford; Hannah Kibuuka; Julie Ake; Rasmi Thomas; Sarah Rowland-Jones; John Rek; Emmanuel Arinaitwe; Moses Kamya; Isabel Rodriguez-Barraquer; Margaret E Feeney; Mary Carrington
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-13       Impact factor: 12.779

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.